In further agreement, in-vitro studies of pancreatic and breast cancer cell lines suggest that the tumor-promoting role of SSH is mainly due to its ability to dephosphorylate Cofilin since the loss of SSH function resulted in the decreased non-phosphorylated Cofilin and metastatic ability of those cell lines [31,47]. Here, CFL1 is linked to breast carcinoma.